pfizer Archives - Page 4 of 5

The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer in adult patients, according to a statement.

Pfizer gets FDA nod for combination drug to treat advanced prostate cancer

HQ Team June 21, 2023: The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer.

by HealthQuill
June 20, 2023
0 Comments

Pfizer Inc. announced a shortage of several doses of penicillin to treat strep throat and other infections in the US, as demand for the drug increased due to a rise in syphilis infection rates.

Drugs Health Pharma

Pfizer warns of penicillin shortage as syphilis rates rise in United States

HQ Team June 14, 2023: Pfizer Inc. announced a shortage of several doses of penicillin to treat strep throat and other infections in.

by HealthQuill
June 14, 2023
0 Comments

Pfizer’s last-stage experimental trials for treating multi-drug-resistant bacteria have yielded positive results, the US-based company announced.

Drugs Health Medical Pharma

Pfizer: ’Positive results’ emerge out of multi-drug-resistant trials

HQ Team June 1, 2023: Pfizer’s last-stage experimental trials for treating multi-drug-resistant bacteria have yielded positive results, the US-based company announced. The Phase.

by HealthQuill
June 1, 2023
0 Comments

Pfizer Inc.’s phase III experimental therapy for treating hemophilia has shown a 92% reduction in bleeding compared to other existing cures, the US-based company stated.

Drugs Health Medical Pharma

Pfizer’s hemophilia trial cure shows 92% cut in bleeds

Pfizer’s hemophilia trial cure shows a 92% cut in bleeds HQ Team May 30, 2023: Pfizer Inc.’s phase III experimental therapy for treating.

by HealthQuill
May 31, 2023
0 Comments

Drugs Medical Pharma

Pfizer suspends sale of 4 antibiotics in India due to manufacturing issues

Pfizer suspends sale of 4 antibiotics in India as there are some deviations observed in the manufacturing process

by HealthQuill
May 19, 2023
0 Comments

Pfizer plans to raise long-term debt worth $31 billion to finance its acquisition of Seagen, according to a company statement.

Drugs Health Medical Pharma

Pfizer to raise $31 billion in long-term debt for Seagen acquisition

HQ Team May 18, 2023: Pfizer plans to raise long-term debt worth $31 billion to finance its acquisition of Seagen, according to a.

by HealthQuill
May 18, 2023
0 Comments

Arbutus Biopharma Corporation and Genevant Sciences filed a lawsuit in a US court seeking compensation for Pfizer and BioNTech’s unlicensed use of its patents in making COVID-19 vaccines.

Drugs Health Medical Pharma

Arbutus drags Pfizer, BioNTech to court over patent infringements

HQ Team April 5, 2023: Arbutus Biopharma Corporation and Genevant Sciences filed a lawsuit in a US court seeking compensation for Pfizer and BioNTech’s unlicensed use.